Omnicell, Inc., provides medication management automation solutions and adherence tools for health care systems and pharmacies in the United States and internationally. The company is headquartered in Mountain View, California.
| Revenue (TTM) | $1.18B |
| Gross Profit (TTM) | $508.04M |
| EBITDA | $45.56M |
| Operating Margin | 2.20% |
| Return on Equity | 0.17% |
| Return on Assets | 0.36% |
| Revenue/Share (TTM) | $25.78 |
| Book Value | $27.36 |
| Price-to-Book | 1.26 |
| Price-to-Sales (TTM) | 1.36 |
| EV/Revenue | 1.304 |
| EV/EBITDA | 16.83 |
| Quarterly Earnings Growth (YoY) | -35.90% |
| Quarterly Revenue Growth (YoY) | 2.30% |
| Shares Outstanding | $45.44M |
| Float | $42.00M |
| % Insiders | 2.44% |
| % Institutions | 106.93% |